Human vaccine against bird flu a reality with new discovery

Mar 02, 2009

A vaccine to protect humans from a bird flu pandemic is within reach after a new discovery by researchers at the University of Melbourne, Australia.

The discovery, published today in the prestigious Proceedings of the National Academy of Sciences, reveals how boosting T cell immunity could better protect humans from a bird flu pandemic.

The continued spread of the highly virulent "bird flu" virus has experts worried that we are facing a new potential influenza pandemic which could transfer between humans. Furthermore, given the bird flu is new, there is no pre-existing immunity in the population and current vaccine formulations would be useless.

"The 'Killer T cell' is the hit-man of the immune system. It is able to locate and destroy virus-infected cells in our body helping rid us of infection," said A/Prof Stephen Turner, from the Department of Microbiology and Immunology at the University of Melbourne who is a lead author on the paper.

"Unfortunately, current influenza vaccines are poor at inducing killer T cell immunity. Therefore, we wanted to see if we could improve the current vaccine formulation to induce killer T cells after vaccination," he said.

"We added a compound, known to increase immunity, to the flu vaccine in an animal model. The addition of this compound promoted significant generation of potent killer T cell immunity and provided protection from infection.

"The significance of these findings is that rather than having to design a new vaccine altogether, we can improve current flu vaccines by adding this potent immune modulator.

"With appropriate clinical testing, we could see improvements to current vaccines within the next five years."

Dr Turner said the key to vaccine effectiveness was ensuring a match between the vaccine and the current circulating flu strain. However, the spike proteins varied over the course of a flu season rendering the current vaccine ineffective. As such, the vaccine needs to be updated every year to match the likely strain for that winter.

"It is a different situation for influenza pandemics. Pandemics arise due to the introduction of a new influenza virus into human circulation. As such, there is little or no pre-existing immunity to the bird flu virus enabling it to spread rapidly."

"'Killer' T cells recognise components that are conserved between different influenza viruses. Therefore, a vaccine strategy that induced killer T cells pre-emptively would provide protection from a potential pandemic."

Source: University of Melbourne

Explore further: Gamers helping in Ebola research

add to favorites email to friend print save as pdf

Related Stories

Panel backs sharing studies of lab-made bird flu

Mar 30, 2012

(AP) -- The U.S. government's biosecurity advisers said Friday they support publishing research studies showing how scientists made new easy-to-spread forms of bird flu because the studies, now revised, don't reveal details ...

Controversial 'bird flu' edits move ahead

Dec 22, 2011

Top US scientists on Wednesday defended their bid to stop details of a mutant bird flu virus from being published and called for global cooperation to ward off an uncontrollable pandemic.

WHO announces deal on sharing flu virus samples

Apr 17, 2011

The World Health Organisation said Saturday an agreement has been reached on sharing flu virus samples, hammered out after intense negotiations by a group on preparations for flu pandemics.

Universal flu vaccine study yields success in mice

Feb 18, 2011

(PhysOrg.com) -- Adelaide researchers have taken a step closer to the development of a universal flu vaccine, with results of a recent study showing that a vaccine delivered by a simple nasal spray could provide ...

Cell-based flu shot beats current vaccine: study

Feb 15, 2011

Flu vaccines made from lab-grown cells work at least as well as those derived from viruses cultivated in chicken eggs, the preferred method for 50 years, according to a study released Wednesday.

SLU findings: Don't pitch stockpiled avian flu vaccine

Feb 09, 2011

A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint ...

Recommended for you

Gamers helping in Ebola research

12 hours ago

Months before the recent Ebola outbreak erupted in Western Africa, killing more than a thousand people, scientists at the University of Washington's Institute for Protein Design were looking for a way to stop the deadly virus.

Carcinogenic role of a protein in liver decoded

14 hours ago

The human protein EGFR controls cell growth. It has mutated in case of many cancer cells or exists in excessive numbers. For this reason it serves as a point of attack for target-oriented therapies. A study ...

A new way to diagnose malaria, using magnetic fields

Aug 31, 2014

Over the past several decades, malaria diagnosis has changed very little. After taking a blood sample from a patient, a technician smears the blood across a glass slide, stains it with a special dye, and ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

Nartoon
3 / 5 (2) Mar 03, 2009
"The continued spread of the highly virulent "bird flu" virus has experts worried". What spread, so far it's no more virulent than any number of other animal illnesses. Try to be less sensational, afte rall we're not pushing AGW here.